Climate Report Signals Potential NearRecord Heat Waves Raising Stakes for Insurance and Energy Sectors
Global Uncertainty Drags Down Overseas Remittances Under LRS by 2 in FY26 RBI Data Shows
Rubio Moves to Calm NATO Allies Amid Uncertainty Over US Troop Deployments
MuskAltman Trial Could Boost AI Industry Transparency
SpaceXs Deleted S1 Disclosure Reveals Stunning Economics of AI Infrastructure Deal with Anthropic
AGX Files Lawsuit Against RR and Huntington Over Frozen Credit Line and Unpaid Carrier Invoices
CZNC Q1 2026 Earnings Massive EPS Miss Shocks Analysts Stock Holds Steady
NCLH Q1 2026 Earnings EPS Beat by 583 Drives Strong Stock Surge
IVR Q1 2026 Earnings Mortgage REIT Slightly Misses EPS Estimates Amid Market Volatility
OVV Q1 2026 Earnings Strong EPS Beat as Operational Efficiency Drives Surprise
TLSI Q1 2026 Earnings EPS Surprises Positively Despite No Revenue Stock Declines
Ryder System Inc R Q1 2026 Earnings EPS Surprises 965 Above Estimates
Lifezone Metals Soars 876 Support and Resistance Levels in Focus
Meiwu Technology WNW Drops 4 as Selling Pressure Builds Near Key Support Level
Tennessee Valley Authority TVE Holds Steady Near Support as Utilities Sector Shows Resilience
Presidio Property Trust Preferred Stock SQFTP Edges Higher Amid Steady Trading
Natures Sunshine Products NATR Holds Steady Near 2184 as Technical Levels Come into Focus
SpaceX Scrubs Starship V3 Test Flight Rescheduled for Friday Launch
3D Systems DDD Q1 2026 Earnings NarrowerThanExpected Loss Drives Share Rally
Deutsche Bank DB Edges Lower Amid Market Uncertainty Key Levels to Watch
Biofrontera Inc BFRI Edges Higher A SmallCap Biotech Finds Temporary Footing
Scully Royalty Ltd SRL Holds Steady at 612 as Traders Eye Key Resistance
Arcutis Biotherapeutics ARQT Moves Higher as Market Digests Recent Developments
Creative Global Technology Holdings Limited CGTL Slips 6 as Stock Tests Key Support Levels
Zura Bio ZURA Slips 18 as Stock Tests Key Support Levels
San Juan Basin Royalty Trust SJT Edges Lower as Energy Sector Consolidates
Zentalis Pharmaceuticals ZNTL Faces Resistance Near 426 After Recent Pullback